Lípidos e prevenção
10 ensaiosVESALIUS-CV2026Evolocumab in Patients at High Cardiovascular Risk without Prior Myocardial Infarction or StrokeCLEAR Outcomes2023Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant PatientsREDUCE-IT2019Reduction of Cardiovascular Events with Icosapent EthylODYSSEY OUTCOMES2018Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With AlirocumabFOURIER2017Further Cardiovascular Outcomes Research with PCSK9 InhibitionCANTOS2017Canakinumab Anti-inflammatory Thrombosis Outcomes StudyIMPROVE-IT2015Improved Reduction of Outcomes: Vytorin Efficacy International TrialJUPITER2008Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating RosuvastatinPROVE-IT2004Pravastatin or Atorvastatin Evaluation and Infection Therapy — Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22)4S1994Scandinavian Simvastatin Survival Study